Drug Discovery Unchained: What The Drug!? #2

webinar

Wed, 14 Aug 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

Drug Discovery Unchained: What The Drug!? #2

What happens when somebody asks you to do drug discovery? No preparation, no script, no nothing. Just live performing and sharing your thoughts.

This is “What The Drug!?”: a live session tackling a drug discovery challenge using BioSolveIT tools, with the aim of reaching a conclusion in a reasonable time frame. What is the challenge? We do not know. Everything will be revealed during the stream, and we will see how things unfold.

The first session was a good starting point, but let’s see how things develop. Dive into the session, discuss together, and explore on-the-fly compound design.

Current news

AuriVerse by Aurigene - Access now with our tools
June 15, 2026 11:00 CEST
We are happy to integrate AuriVerse to our portfolio of Chemical Spaces, created in collaboration between Aurigene Pharmaceutical Services and BioSolveIT. AuriVerse marks our first Chemical Space partnership with a company based in India, extending the portfolio into a new region of expert make-on-demand chemistry. AuriVerse brings a precision-engineered universe...
Read on
Space Merge!! Synple Space merging with eXplore
June 8, 2026 11:50 CEST
Following the merger of eMolecules and Synple, the eXplore and Synple Space collections have come together as a single Chemical Space. Created by eMolecules together with BioSolveIT, it spans 8,336,928,869,958 products, more than 8.3 trillion in total. For now, both Spaces are listed separately on the website, though their content...
Read on
Tool of the Month - infiniSee 7.1 'Arke'
May 27, 2026 09:44 CEST
Navigate Chemical Space with infiniSee 7.1 ‘Arke’ The ultimate platform for exploring ultra-large Chemical Spaces is taking a huge leap forward. Combining our Tool of the Month series with an exciting software release, we are happy to present infiniSee 7.1 ‘Arke’. Allowing you to search deeper and evaluate compounds more...
Read on